Targeting MerTK Enhances Adaptive Immune Responses After Radiation Therapy is a research paper published in International Journal of Radiation Oncology*Biology*Physics (2020). On theSindex it has a DataRank of 0.510. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Radiological Society of North America
Grant: RR1972
Radiological Society of North America
Grant: RO1HL101972
Radiological Society of North America
Grant: R01GM116184
National Institutes of Health
Grant: R21AI126151
National Institutes of Health
Grant: R01CA182311
National Institutes of Health
Grant: R01CA208644
NCI NIH HHS
Grant: R01 CA244142
NHLBI NIH HHS
Grant: R01 HL101972
National Institutes of Health
Grant: 5R21AI126151-02
Increasing the potency of Listeria monocytogenes-based vaccines by eliminating vaccine-related gamma delta T cell responses.
National Institutes of Health
Grant: 5R01GM116184-04
FXI and Sepsis
National Institutes of Health
Grant: 5R01CA182311-05
High dose radiation therapy to direct immune responses to pancreatic cancer
National Institutes of Health
Grant: 5R01CA208644-05
(PQ11) Targeting STING in the context of chemoradiation therapy to overcome poor preexisting immunity in mouse models of pancreatic cancer.
National Institutes of Health
Radiological Society of North America
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals